Literature DB >> 29286212

Knockdown of CPEB4 expression suppresses cell migration and invasion via Akt pathway in non-small cell lung cancer.

Jing Hu1, LiBin Zhang1, Qiang Chen1, Jie Lin1, ShaoBo Wang1, Ri Liu1, WenJing Zhang1, Kun Miao1, Tao Shou1.   

Abstract

Cytoplasmic polyadenylation element binding protein 4 (CPEB4) could be an important regulator in variety of cancers. However, the biological function and the underlying molecular mechanism of CPEB4 in non-small cell lung cancer (NSCLC) remains unknown. In this study, we investigated the metastasis role of CPEB4 in NSCLC cells, we knocked down CPEB4 using siRNA. Transwell migration assay and cell invasion assay on Matrigel were presented, and cell migration was also determined by scratch-healing assay. ROS generation were determined by fluorescence probe DCFH2-DA. The protein expression was assessed by ELISA and Western blot analysis. LY294002 were used to inhibit PI3 K/Akt signaling. The data showed that knockdown of CPEB4 inhibited the migration and invasion of NSCLC. Moreover, silencing of CPEB4 reduced Snail and MMP-3 expression in vitro. We also indicated that CPEB4 knockdown increased the ROS expression. Furthermore, we found that silencing of CPEB4 decreased pAkt expression. Taken all together, our data demonstrated that silencing of CPEB4 induces ROS generation, thus suppressing the Akt expression, which finally prevents NSCLC cells invasion and migration. Therefore, CPEB4 may regard as a target to inhibit NSCLC invasion and metastasis through Akt pathway.
© 2018 International Federation for Cell Biology.

Entities:  

Keywords:  CPEB4; invasion; migration; non-small cell lung cancer

Mesh:

Substances:

Year:  2018        PMID: 29286212     DOI: 10.1002/cbin.10930

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  4 in total

1.  A meta-analysis of multiple matched aCGH/expression cancer datasets reveals regulatory relationships and pathway enrichment of potential oncogenes.

Authors:  Richard Newton; Lorenz Wernisch
Journal:  PLoS One       Date:  2019-07-23       Impact factor: 3.752

2.  Astragaloside IV Inhibits the Progression of Non-Small Cell Lung Cancer Through the Akt/GSK-3β/β-Catenin Pathway.

Authors:  Liwei Jia; Dongying Lv; Shuang Zhang; Zhenyue Wang; Bo Zhou
Journal:  Oncol Res       Date:  2018-08-21       Impact factor: 4.938

3.  CircESRP1 enhances metastasis and epithelial-mesenchymal transition in endometrial cancer via the miR-874-3p/CPEB4 axis.

Authors:  Rui Shi; Wei Zhang; Jun Zhang; Zhicheng Yu; Lanfen An; Rong Zhao; Xing Zhou; Ziwei Wang; Sitian Wei; Hongbo Wang
Journal:  J Transl Med       Date:  2022-03-22       Impact factor: 5.531

4.  Circular RNA Circ_0003221 Promotes Cervical Cancer Progression by Regulating miR-758-3p/CPEB4 Axis.

Authors:  Haihui Xie; Jian Wang; Baiqi Wang
Journal:  Cancer Manag Res       Date:  2021-07-05       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.